1. Home
  2. ZBIO vs XPER Comparison

ZBIO vs XPER Comparison

Compare ZBIO & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBIO
  • XPER
  • Stock Information
  • Founded
  • ZBIO 2019
  • XPER 1990
  • Country
  • ZBIO United States
  • XPER United States
  • Employees
  • ZBIO N/A
  • XPER N/A
  • Industry
  • ZBIO
  • XPER Semiconductors
  • Sector
  • ZBIO
  • XPER Technology
  • Exchange
  • ZBIO NYSE
  • XPER Nasdaq
  • Market Cap
  • ZBIO 389.2M
  • XPER 354.5M
  • IPO Year
  • ZBIO 2024
  • XPER 2003
  • Fundamental
  • Price
  • ZBIO $9.80
  • XPER $7.70
  • Analyst Decision
  • ZBIO Strong Buy
  • XPER Strong Buy
  • Analyst Count
  • ZBIO 7
  • XPER 3
  • Target Price
  • ZBIO $32.29
  • XPER $19.00
  • AVG Volume (30 Days)
  • ZBIO 131.3K
  • XPER 353.9K
  • Earning Date
  • ZBIO 05-15-2025
  • XPER 05-07-2025
  • Dividend Yield
  • ZBIO N/A
  • XPER N/A
  • EPS Growth
  • ZBIO N/A
  • XPER N/A
  • EPS
  • ZBIO N/A
  • XPER N/A
  • Revenue
  • ZBIO $15,000,000.00
  • XPER $488,877,000.00
  • Revenue This Year
  • ZBIO N/A
  • XPER $0.50
  • Revenue Next Year
  • ZBIO N/A
  • XPER $8.71
  • P/E Ratio
  • ZBIO N/A
  • XPER N/A
  • Revenue Growth
  • ZBIO N/A
  • XPER N/A
  • 52 Week Low
  • ZBIO $5.83
  • XPER $6.29
  • 52 Week High
  • ZBIO $26.25
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • ZBIO N/A
  • XPER 51.61
  • Support Level
  • ZBIO N/A
  • XPER $7.62
  • Resistance Level
  • ZBIO N/A
  • XPER $7.97
  • Average True Range (ATR)
  • ZBIO 0.00
  • XPER 0.21
  • MACD
  • ZBIO 0.00
  • XPER -0.03
  • Stochastic Oscillator
  • ZBIO 0.00
  • XPER 26.55

About ZBIO ZENAS BIOPHARMA INC

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: